Status:
COMPLETED
Imaging Feature of SARS-CoV2 Infection
Lead Sponsor:
Francesco De Cobelli
Conditions:
Viral Pneumonia
COVID
Eligibility:
All Genders
Brief Summary
The novel coronavirus SARS-CoV2 clinically presents with pneumonia, characterised by fever, cough, dyspnea. The severity of the disease varies widely with evidence of mild disease in the majority of c...
Detailed Description
In March 2020, the third highest number of positive cases in the world was recorded in Italy, mainly due to 2 outbreaks of 2 different clusters in Lombardy and Veneto. Fever is the most common sympto...
Eligibility Criteria
Inclusion
- CoViD-19 positive patients (rRT-PCR naso-pharyngeal swab)
- Suspicion of SARS-CoV2 on chest X-ray and/or chest CT presentation of disease
- Patients of all ages
- Subjects at risk (minors, patients in emergency situations, pregnant women, potentially incapable of giving their consent )
- Having signed the Informed Consent
Exclusion
- Not fulfilling any of the above
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04394026
Start Date
April 16 2020
End Date
December 30 2021
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deaprtment of Radiology, IRCCS Ospedale San Raffaele
Milan, Italy, 20132